Oct 20, 2026 06:49AM
Sep 2, 2026 08:00AM
Aug 20, 2026 06:57AM
Jul 16, 2026 06:49AM
Jul 9, 2026 06:49AM
Jun 3, 2026 06:53AM
May 18, 2026 07:04AM H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
May 11, 2026 07:12AM
May 7, 2026 08:00AM
Aug 21, 2025 08:00AM
Aug 11, 2025 06:39AM
Jul 8, 2025 06:50AM
Jun 16, 2025 06:34AM
Mar 11, 2025 06:42AM UroGen Pharma (URGN) PT Lowered to $55 at H.C. Wainwright
Feb 25, 2025 06:52AM
Oct 15, 2024 06:33AM
Oct 3, 2024 06:57AM
Aug 29, 2024 08:00AM
Aug 16, 2024 06:47AM
Jul 1, 2024 06:40AM
Jun 17, 2024 10:51PM UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
Jun 14, 2024 06:35AM
May 7, 2024 08:00AM
Aug 31, 2023 08:00AM
Jul 27, 2023 09:55AM
Jul 27, 2023 09:55AM
Apr 25, 2023 08:00AM
Sep 7, 2022 04:00PM UroGen Pharma Announces Upcoming 2022 Conferences
May 18, 2022 08:00AM
Jan 5, 2022 08:00AM
Sep 10, 2021 08:00AM
Sep 10, 2020 08:00AM
Sep 10, 2019 08:00AM
Mar 1, 2019 09:06AM
Jan 29, 2019 07:32AM UPDATE: H.C. Wainwright Starts UroGen Pharma (URGN) at Buy

22,650 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All